Compelling preclinical [171] and clinical [172, 173] evidence shows that targeting the VEGF and ANG2-Tie2-pathways seems to extend the transient window of vascular normalization and stimulates the intrinsically immunosuppressive tumor microenvironment (TME) in NSCLC and other solids tumors. This evidence concerns the gene VEGFA and neoplasm.